What is RARE's EasyStocksAI score?

Ultragenyx Pharmaceutical Inc (RARE) scores 19 out of 100 on EasyStocksAI's Graham-inspired scoring system. Breakdown: Total Shareholder Yield: 0/25, Return Consistency: 0/25, Return Growth: 0/25, Payment Regularity: 0/25, Revenue Growth: 6/25, Earnings Growth: 0/25, Margin Trend: 2/25, Capital Efficiency: 0/25, P/E vs Sector: 0/25, Graham Ratio Trend: 0/25, Price Stability: 0/25, Earnings Yield: 0/25, 10Y SPY Outperformance: 0/25, 10Y Sector Outperformance: 0/25, Crisis Resilience: 11/25.

Does RARE pay dividends?

Ultragenyx Pharmaceutical Inc does not currently pay a regular dividend.

insights

EasyStocksAI

RAR

RARE

Ultragenyx Pharmaceutical Inc

$21.71 arrow_downward $0.50 (2.25%)

AI Score

N/A

Loading chart…

Loading chart...

analytics Financial Highlights

P/E Ratio ⚠ Neg. EPS

Dividend Yield 0.00%

Graham Number ⚠ Neg. EPS

Market Cap $2.1B

Div. Increase Years 0

Continuous Years 0

Crises Survived 1

speed Performance Benchmarks

vs S&P 500 (10Y) -415.12%

vs Sector (10Y) -213.59%

speed Market Sentiment

Fear

OVERALL MARKET CONFIDENCE

show_chart Trend Analysis

Primary Trend

▼ Downtrend

Secondary Trend Bearish

Warning Price rose above 20-day MA

MA 20

22.03

MA 50

23.08

MA 200

30.00

analytics Sector Comparison (Health Care)

P/E Ratio Neg. EPS

Graham Ratio Neg. EPS

Track RARE and 1,000+ stocks for free

Get scores, alerts, and portfolio tracking — no credit card required.

Start Free →